Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding unaudited financial results for the quarter and half year ended September 30, 2025.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has informed the stock exchanges about the publication of its unaudited financial results for the quarter and half year ended September 30, 2025, in newspapers as required by SEBI listing regulations. The newspaper publication is a standard compliance step that follows the board's approval and submission of quarterly results to the exchanges. This filing does not contain new financial figures itself but confirms that the results have been made publicly available in print media for wider shareholder access. Investors should refer to the earlier filed financial results for the actual numbers and performance details.
This is a routine regulatory disclosure with no direct impact on the stock price. It simply confirms wider public dissemination of already-disclosed Q2/H1 FY26 results, ensuring retail shareholders who rely on newspapers are informed.